1-2 months / not 30 - 90 days that we have only he
Post# of 158771
"The trick is getting those cold tumors to turn hot. And that's where the excitement with leronlimab is that we saw that patients who got one of the two higher doses, both of which were well tolerated, 88% of those women had their tumors go from cold to hot over a period of one to two months."
That is a huge comment for us
___
" we've spoken to quite a number of the pharmaceutical entities that have checkpoint assets, and they're really just waiting to see us confirm this signal prospectively before diving in, because it gives them an opportunity, not only will patients benefit, but it'll give the companies an opportunity to vastly expand their markets. "
$$$ is all the ICI's see after talking to Dr. J
___
"So I never forget for a day how urgent this is to prospectively show our signal, bring a partner on board, and launch the kind of studies that'll bring an FDA approval as quickly as possible."
Mid 2024, Dr. J said fastest ROI for shareholders is a significant partnership, &/or, FDA approval
___
"But what's really gratifying is I think we have a clear sight now to where this company needs to go and how to get this drug approved for patients."
Rx video, Dr. J said paradigm shift after 3 minutes. This interview he said paradigm shift --- in the 1st paragraph.
Wow @ the confidence !!
___
Thanks to u2rocksme for taking time/effort to post sections of this interview
https://stocktwits.com/u2rocksme/message/636316670